Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.2.835

miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in Gastric Cancer  

Qin, Shuang (Department of General Surgery, First Affiliated Hospital of Xinxiang Medical University)
Ai, Fang (Department of Pediatric Surgery, First Affiliated Hospital of Xinxiang Medical University)
Ji, Wei-Fang (Department of Pediatric Surgery, First Affiliated Hospital of Xinxiang Medical University)
Rao, Wang (Department of Pediatric Surgery, First Affiliated Hospital of Xinxiang Medical University)
Zhang, He-Cheng (Department of Pediatric Surgery, First Affiliated Hospital of Xinxiang Medical University)
Yao, Wen-Jian (Department of Thoracic Surgery, First Affiliated Hospital of Xinxiang Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.2, 2013 , pp. 835-840 More about this Journal
Abstract
Accumulating evidence has shown that microRNAs are involved in cancer development and progression. However, it remains unknown about the potential role of miR-19a in the pathogenesis of gastric cancer. Here, we report that suppressor of cytokine signaling 1 (SOCS1) is a novel target of miR-19a in gastric cancer cells and that miR-19a expression is inversely correlated with SOCS1 expression in gastric cancer cells and a subset of gastric cancer tissues. Ectopic expression of miR-19a dramatically promoted proliferation and tumorigenicity of gastric cancer cells both in vitro and in vivo. Moreover, we showed that silencing of SOCS1 promoted cell growth and colony formation resembling that of miR-19a overexpression, whereas re-introduction of SOCS1 (without the 3'-UTR) attenuated the pro-tumorigenic functions. Taken together, our findings suggest that the SOCS1 gene is a direct target of miR-19a, which functions as an oncogenic miRNA in gastric cancer by repressing the expression of tumor suppressor SOCS1.
Keywords
SOCS1; miR-19a; gastric cancer; cell growth;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-33.   DOI   ScienceOn
2 Clevenger CV (2004). Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol, 165, 1449-60.   DOI   ScienceOn
3 Davey GM, Heath WR, Starr R (2006). SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens, 67, 1-9.
4 Ding L, Xu Y, Zhang W, et al (2010). MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res, 20, 784-93.   DOI   ScienceOn
5 Du Y, Xu Y, Ding L, et al (2009). Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol, 44, 556-61.   DOI
6 Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69.   DOI   ScienceOn
7 Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9, 102-14.
8 Friedman RC, Farh KK, Burge CB, et al (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res, 19, 92-105.
9 Gao C, Zhang Z, Liu W, et al (2010). Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer, 116, 41-9.
10 Guo X, Guo L, Ji J, et al (2010). miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun, 398, 1-6.   DOI   ScienceOn
11 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
12 Jiang S, Zhang HW, Lu MH, et al (2010). MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res, 70, 3119-27.   DOI   ScienceOn
13 Krebs DL, Hilton DJ (2001). SOCS proteins: negative regulators of cytokine signaling. Stem Cells, 19, 378-87.   DOI   ScienceOn
14 Lai RH, Hsiao YW, Wang MJ, et al (2010). SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation. Cancer Lett, 288, 75-85.   DOI   ScienceOn
15 Lee TL, Yeh J, Van Waes C, et al (2006). Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Mol Cancer Ther, 5, 8-19.
16 Liu M, Wang Z, Yang S, et al (2011). TNF-$\alpha$ is a novel target of miR-19a. Int J Oncol, 38, 1013-22.
17 Oshimo Y, Kuraoka K, Nakayama H, et al (2004). Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. Int J Cancer, 112, 1003-9.   DOI   ScienceOn
18 Ouchida M, Kanzaki H, Ito S, et al (2012). Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach. PLoS One, 7, e44095.   DOI
19 Pichiorri F, Suh SS, Ladetto M, et al (2008). MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA, 105, 12885-90.   DOI   ScienceOn
20 Shi Y, Zhou Y (2010). The role of surgery in the treatment of gastric cancer. J Surg Oncol, 101, 687-92.   DOI   ScienceOn
21 Slattery ML, Lundgreen A, Kadlubar SA, et al (2013). JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. Mol Carcinog, 52, 155-66.   DOI   ScienceOn
22 Souma Y, Nishida T, Serada S, et al (2012). Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells. Int J Cancer, 131, 1287-96.   DOI   ScienceOn
23 Ueda T, Volinia S, Okumura H, et al (2010). Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol, 11, 136-46.   DOI   ScienceOn
24 Wu Q, Jin H, Yang Z, et al (2010). MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun, 392, 340-45.   DOI   ScienceOn
25 Xu XM, Wang XB, Chen MM, et al (2012). MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett, 322, 148-58.   DOI   ScienceOn
26 Zhang Z, Li Z, Gao C, et al (2008). miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest, 88, 1358-66.   DOI   ScienceOn